UBS Maintains Neutral on Eastman Chemical, Raises Price Target to $89
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has maintained a Neutral rating on Eastman Chemical (NYSE:EMN) and increased the price target from $81 to $89.
December 14, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS has maintained a Neutral rating on Eastman Chemical and raised the price target from $81 to $89, indicating a positive outlook on the stock's value.
The increase in price target by UBS suggests a more optimistic valuation of Eastman Chemical's stock, which could lead to a positive short-term impact on its share price. However, since the rating remains Neutral, the impact may not be as significant as it would be with an upgrade to a Buy rating.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100